MM-359 Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens (srs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Sub-Analysis of Black Patients
Clinical Lymphoma Myeloma and Leukemia（2024）
关键词
MM,CAR T cell therapy,multiple myeloma,triple-class exposed,progression-free survival,safety,phase 3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要